| Literature DB >> 25347854 |
Keisho Katayama1, Koji Ishida1, Mitsuru Saito2, Teruhiko Koike1, Ai Hirasawa3, Shigehiko Ogoh3.
Abstract
Muscle sympathetic nerve activity (MSNA) is not increased during leg cycling at light and mild intensities, despite activation of central command and the exercise pressor reflex. We determined whether increasing central blood volume and loading the cardiopulmonary baroreceptors modulate sympathetic vasomotor outflow during leg cycling. To this end, we changed the pedaling frequency to enhance skeletal muscle pump. Subjects performed two leg cycle exercises at differential pedal rates of 60 and 80 rpm (60EX and 80EX trials) for two conditions (with and without MSNA measurement). In each trial, subjects completed leg cycling with a differential workload to maintain constant oxygen consumption (VO2). MSNA was recorded via microneurography at the right median nerve of the elbow. Without MSNA measurement, thoracic impedance, stroke volume (SV), and cardiac output (CO) were measured non-invasively using impedance cardiography. Heart rate and VO2 during exercise did not differ between the 60EX and 80EX trials. Changes in thoracic impedance, SV, and CO during the 80EX trial were greater than during the 60EX trial. MSNA during the 60EX trial was unchanged compared with that at rest (25.8 ± 3.1 [rest] to 28.3 ± 3.4 [exercise] bursts/min), whereas a significant decrease in MSNA was observed during the 80EX trial (25.8 ± 2.8 [rest] to 19.7 ± 2.0 [exercise] bursts/min). These results suggest that a muscle pump-induced increase in central blood volume, and thereby loading of cardiopulmonary baroreceptors, could inhibit sympathetic vasomotor outflow during mild dynamic leg exercise, despite activation of central command and the exercise pressor reflex.Entities:
Keywords: cardiopulmonary baroreceptors; dynamic leg exercise; sympathetic activity
Year: 2014 PMID: 25347854 PMCID: PMC4187562 DOI: 10.14814/phy2.12070
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Respiratory, cardiovascular and MSNA variables during experiment
| Trials | Rest | Exercise | Recovery | |
|---|---|---|---|---|
| VE (L/min) | 60EX | 11.4 ± 1.0 | 32.9 ± 2.0* | 24.0 ± 1.2* |
| 80EX | 11.3 ± 0.4 | 33.4 ± 1.5† | 22.5 ± 1.7† | |
| VT (L) | 60EX | 0.65 ± 0.10 | 1.38 ± 0.08* | 1.39 ± 0.11* |
| 80EX | 0.65 ± 0.04 | 1.39 ± 0.11† | 1.30 ± 0.10† | |
| f (breaths/min) | 60EX | 15.3 ± 1.4 | 23.9 ± 1.4* | 18.2 ± 1.7* |
| 80EX | 15.6 ± 1.1 | 24.5 ± 2.1†§ | 19.0 ± 1.3† | |
| VO2 (L/min) | 60EX | 0.28 ± 0.02 | 1.22 ± 0.06* | 0.82 ± 0.06* |
| 80EX | 0.29 ± 0.02 | 1.23 ± 0.07† | 0.79 ± 0.05† | |
| VCO2 (L/min) | 60EX | 0.22 ± 0.01 | 1.14 ± 0.04* | 0.74 ± 0.05* |
| 80EX | 0.23 ± 0.02 | 1.16 ± 0.05† | 0.74 ± 0.05† | |
| SBP (mmHg) | 60EX | 120.0 ± 3.3 | 153.2 ± 7.4* | 140.5 ± 8.9* |
| 80EX | 120.5 ± 6.2 | 152.8 ± 8.4† | 141.3 ± 9.4† | |
| DBP (mmHg) | 60EX | 68.2 ± 4.3 | 63.5 ± 2.8 | 71.8 ± 2.2 |
| 80EX | 71.7 ± 3.0 | 64.3 ± 4.2 | 68.8 ± 2.8 | |
| MBP (mmHg) | 60EX | 84.8 ± 3.5 | 91.4 ± 4.4* | 94.7 ± 2.4* |
| 80EX | 87.7 ± 3.5 | 90.8 ± 2.4† | 93.0 ± 4.4 | |
| MSNA BI (bursts/100 HR) | 60EX | 38.7 ± 3.6 | 28.2 ± 3.1* | 39.9 ± 5.9 |
| 80EX | 41.3 ± 3.7 | 18.3 ± 1.8†§ | 34.8 ± 5.1 |
Values are mean ± SE (n = 6). Values are averaged over the last minutes of each session. VE, expired minute ventilation; VT, tidal volume; f, breathing frequency; VO2, oxygen uptake; VCO2, carbon dioxide output; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; MSNA BI, muscle sympathetic nerve activity bursts incidence; *P < 0.05 vs. at Rest in the 60EX trial. †P < 0.05 vs. at Rest in the 80EX trial. §P < 0.05 60EX vs. 80EX.
Figure 1.Changes in HR (A), SV (B), and CO (C) during the 60EX and 80EX trials. *P < 0.05 vs. the last minute of rest in the 60EX trial. †P < 0.05 vs. the last minute rest in the 80EX trial. §P < 0.05 when comparing the 60EX and 80EX trials.
Figure 2.Changes in thoracic impedance ((Z values) from rest to exercise in the 60EX and 80EX trials. §P < 0.05 when comparing the 60EX and 80EX trials.
Cardiac variables in the Doppler test
| Trials | Rest | Exercise | Recovery | |
|---|---|---|---|---|
| HR (beats/min) | 60EX | 70.0 ± 2.8 | 104.5 ± 4.1* | 78.0 ± 4.2* |
| 80EX | 71.2 ± 1.4 | 105.5 ± 3.1† | 79.0 ± 3.7† | |
| SV (mL) | 60EX | 83.0 ± 4.1 | 106.6 ± 6.9* | 100.2 ± 5.9* |
| 80EX | 81.5 ± 4.6 | 114.6 ± 7.4†§ | 100.8 ± 3.9† | |
| CO (L/min) | 60EX | 5.9 ± 0.2 | 11.5 ± 0.6* | 7.7 ± 0.3* |
| 80EX | 5.8 ± 0.3 | 12.3 ± 0.6†§ | 7.9 ± 0.3† |
Values are mean ± SE (n = 5). Values are averaged over the last 30 sec of each session. HR, heart rate; SV, stroke volume; CO, cardiac output. SV and CO were obtained by the Doppler echocardiography. *P < 0.05 vs. at Rest in the 60EX trial. †P < 0.05 vs. at Rest in the 80EX trial. §P < 0.05 60EX trial vs. 80EX trial.
Figure 3.Representative ECG and MSNA recordings made during the 60EX and 80 EX trials.
Figure 4.Changes in MSNA BF in the 60EX and 80 EX trials. *P < 0.05 vs. the last minute of rest in the 60EX trial. †P < 0.05 vs. the last minute of rest in the 80EX trial. §P < 0.05 when comparing the 60EX and 80EX trials.